景岳生物科技股份有限公司 News Releases

King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.6… · 2025-12-01

GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit … · 2026-03-01

King's Group Biotech Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 0.6… · 2025-12-01

GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit … · 2026-03-01